Literature DB >> 33665906

Sirtuin GdSir2.4 participates in the regulation of rRNA transcription in the Giardia duodenalis parasite.

Francisco Alejandro Lagunas-Rangel1, Janet Yee2, María Luisa Bazán-Tejeda1, Enrique García-Villa1, Rosa María Bermúdez-Cruz1.   

Abstract

Giardia duodenalis is a parasite of great medical interest due to the number of infections it causes worldwide each year. Although research on epigenetic mechanisms in this protist has only begun recently, epigenetic regulation has already been shown to have important roles in encystation, antigenic variation, and resistance to antibiotics in Giardia. In this work, we show that a Giardia ortholog of Sir2, GdSir2.4, is involved in the silencing of rRNA expression. Our results demonstrate that GdSir2.4 localizes to the nucleolus, and its binding to the intergenic spacer region of the rDNA is associated with the deacetylation of the chromatin in this region. Given the importance of the regulation of rRNA expression to maintain adequate levels of ribosomes and genomic stability within the cells, GdSir2.4 can be considered a target to create new therapeutic agents against this parasite.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  ChIP; cell cycle; deacetylation; gene silencing; sirtuins

Year:  2021        PMID: 33665906     DOI: 10.1111/mmi.14710

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  3 in total

1.  Ribosomal RNA Transcription Machineries in Intestinal Protozoan Parasites: A Bioinformatic Analysis.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Acta Parasitol       Date:  2022-08-27       Impact factor: 1.534

Review 2.  SIRT7 in the aging process.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Cell Mol Life Sci       Date:  2022-05-18       Impact factor: 9.207

Review 3.  G protein-coupled receptors that influence lifespan of human and animal models.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Biogerontology       Date:  2021-12-03       Impact factor: 4.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.